Drugs / IDCT
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03347708 | Feb 2018 → Feb 2022 | lumbar disk degenerative disorder | DiscGenics, Inc. | Completed | Met primary |
Press releases naming this drug 7 releases
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IDCT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03347708 ↗ |
| Modality | Cell therapy | “In vitro and in vivo evaluation of discogenic cells, an investigational cell therapy for disc degeneration.” PMID 31442616 ↗ Aug 2019 |
| Route | Other | “Single intradiscal injection with High Dose IDCT (9M cells).” NCT03347708 ↗ |